MedPath

University Of California, San Francisco

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer

Phase 2
Conditions
Kidney Cancer
First Posted Date
2003-01-27
Last Posted Date
2014-01-06
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00030888
Locations
🇺🇸

UCSF Comprehensive Cancer Center, San Francisco, California, United States

🇺🇸

Veterans Affairs Medical Center - San Francisco, San Francisco, California, United States

Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

Phase 2
Completed
Conditions
Non-melanomatous Skin Cancer
First Posted Date
2003-01-27
Last Posted Date
2013-06-26
Lead Sponsor
University of California, San Francisco
Target Recruit Count
60
Registration Number
NCT00023621
Locations
🇺🇸

UCSF Comprehensive Cancer Center, San Francisco, California, United States

🇺🇸

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York, New York, United States

Herbal Therapy in Treating Women With Metastatic Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
First Posted Date
2003-01-27
Last Posted Date
2012-09-17
Lead Sponsor
University of California, San Francisco
Target Recruit Count
21
Registration Number
NCT00028977
Locations
🇺🇸

UCSF Comprehensive Cancer Center, San Francisco, California, United States

🇺🇸

Cancer Research Network, Incorporated, Plantation, Florida, United States

Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
Drug/Agent Toxicity by Tissue/Organ
First Posted Date
2003-01-27
Last Posted Date
2011-02-23
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00028964
Locations
🇺🇸

UCSF Comprehensive Cancer Center, San Francisco, California, United States

A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma

Phase 1
Completed
Conditions
Sarcoma, Kaposi
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00002262
Locations
🇺🇸

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco, California, United States

Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)

Not Applicable
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00002031
Locations
🇺🇸

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco, California, United States

A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease

Not Applicable
Completed
Conditions
Mycobacterium Avium-intracellulare Infection
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00002058
Locations
🇺🇸

Keith Med Group, Los Angeles, California, United States

🇺🇸

San Francisco Gen Hosp, San Francisco, California, United States

Diuretics, Hypertension, and Arrhythmias Clinical Trial

Phase 3
Completed
Conditions
Cardiovascular Diseases
Death, Sudden, Cardiac
Heart Arrest
Heart Diseases
Hypertension
First Posted Date
1999-10-28
Last Posted Date
2013-09-19
Lead Sponsor
University of California, San Francisco
Target Recruit Count
233
Registration Number
NCT00000525

Inhaled NO in Prevention of Chronic Lung Disease

Phase 3
Completed
Conditions
Bronchopulmonary Dysplasia
Lung Diseases
First Posted Date
1999-10-28
Last Posted Date
2015-03-05
Lead Sponsor
University of California, San Francisco
Registration Number
NCT00000548
© Copyright 2025. All Rights Reserved by MedPath